These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 12100750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L, Liu GQ.
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [Abstract] [Full Text] [Related]

  • 3. P glycoprotein regulated transport of glutamate at blood brain barrier.
    Liu XD, Liu GQ.
    Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
    [Abstract] [Full Text] [Related]

  • 4. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 5. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells.
    Zhu HJ, Liu GQ.
    Acta Pharmacol Sin; 2003 Nov; 24(11):1143-9. PubMed ID: 14627500
    [Abstract] [Full Text] [Related]

  • 6. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
    Yang ZY, Liu GQ.
    Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
    [Abstract] [Full Text] [Related]

  • 7. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 8. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 9. P-glycoprotein restricted transport of nimodipine across blood-brain barrier.
    Zhang L, Liu XD, Xie L, Wang GJ.
    Acta Pharmacol Sin; 2003 Sep; 24(9):903-6. PubMed ID: 12956939
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L, Zhao C, Yan M, Zhang LY, Xia YZ.
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [Abstract] [Full Text] [Related]

  • 11. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 12. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q.
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [Abstract] [Full Text] [Related]

  • 13. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [Abstract] [Full Text] [Related]

  • 14. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 15. CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.
    Ji BS, He L, Li XQ, Liu GQ.
    Acta Pharmacol Sin; 2006 Apr; 27(4):414-8. PubMed ID: 16539840
    [Abstract] [Full Text] [Related]

  • 16. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
    Bachmeier CJ, Trickler WJ, Miller DW.
    Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
    [Abstract] [Full Text] [Related]

  • 17. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M, Tamai I, Kato H, Nagata O, Tsuji A.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
    [Abstract] [Full Text] [Related]

  • 18. Modulation of P-glycoprotein function by amlodipine derivatives in brain microvessel endothelial cells of rats.
    Ji BS, He L, Liu GQ.
    Acta Pharmacol Sin; 2005 Feb; 26(2):166-70. PubMed ID: 15663893
    [Abstract] [Full Text] [Related]

  • 19. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
    Zhang DM, He ZW, Liu XD, Li Y, Xie L, Wang GJ, Liu L.
    J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
    [Abstract] [Full Text] [Related]

  • 20. Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
    Yang HW, Liu HY, Liu X, Zhang DM, Liu YC, Liu XD, Wang GJ, Xie L.
    Neurosci Lett; 2008 Apr 04; 434(3):299-303. PubMed ID: 18313849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.